NewsBenzinga高盛恢复对革命药物的买入评级，并宣布267美元的目标股价 高盛恢复对革命药物的买入评级，并宣布267美元的目标股价 Benzinga 2026.09.24 12:21 (GMT+0) Open on Benzinga Other news Elon Musk Says Optimus, Cybercab Will Be ‘the Vast Majority’ of Tesla’s Value iPhone Duo Preorders, AAPL Crosses $5 Trillion and More: This Week in Appleverse Wall Street Week Ahead Nscale's IPO plans hit another snag: Microsoft exits data center project Inflation Shakes Fed Outlook Crude Oil Surges, Sanders Targets Oil Companies and More: This Week in Economy AI Investment Impact Understated In U.S. 'It' Market: Texas Reveals
Inflation Shakes Fed Outlook Crude Oil Surges, Sanders Targets Oil Companies and More: This Week in Economy
